For Research Use Only. Not for Human Consumption.
Recorded market$80.10Recorded exact-size market estimate: 80.10 USD for one 5 mg container (16.019400 USD/mg). Arithmetic mean of 10 recorded supplier prices for this same vial or container size and formulation, with no extrapolation from other sizes. Supplier observation dates: Oct 10, 2026 UTC to Oct 11, 2026 UTC. Non-USD prices use ECB exchange rates dated October 9, 2026. Shipping excluded; supplier tax treatment is retained as recorded. This is a dated price comparison, not a former Peptide Serum price or an assurance of potency, purity, dosing or medical equivalence.Public price$80.00Member price$46.1742.3% lessMembers save $33.93 on this item vs. recorded market
ERR agonist studied as an exercise-mimetic in preclinical work.
Exact-size price research
Supplier observation dates: Oct 10, 2026 UTC to Oct 11, 2026 UTC. This reference uses recorded prices for the same 5 mg vial or container and formulation. No prices are extrapolated from smaller or larger vials. Peptide Serum member unit prices refresh from the current catalog. Paid PRO membership is required for member pricing.
$9.23/mg42.3% less
Peptide Serum reference: Member unit price (USD), available with verified paid PRO membership; excludes shipping and applicable taxes. Read from catalog: Oct 23, 2026 04:30 UTC. 1 x 5 mg = 5 mg total.
Source: PeptideSerum-exact-size-market-comparison.xlsx. One selected single-container price per supplier domain, for the same labeled vial size and formulation. Blends match recorded component amounts. The arithmetic mean uses the first ten selected supplier prices in recorded Google discovery order, or the true smaller sample when ten could not be found. No size scaling, mg-to-IU conversion, pack discount or minimum price range is substituted.
The green percentage, when shown, compares the member price for every visitor: (recorded exact-size market average minus Peptide Serum member price) divided by the recorded market average. Unrounded values are used and the percentage is rounded down to one decimal. It is omitted when the member price is equal to or above the reference or the refreshed snapshot cannot be confirmed. Member pricing requires verified paid PRO membership.
These are dated price observations, not live available supplier offers. Shipping is excluded. Supplier tax treatment is retained as recorded and can differ. Memberships, clinical qualifications, ancillary supplies and availability can affect comparability; source notes retain these limitations. Some observations were sold out. Seller domains may be correlated through one manufacturer. This is not a revenue-ranked or complete-market survey.
Non-USD native prices are converted using ECB reference rates dated October 9, 2026. Recorded exchange-rate source. Original prices and currencies are shown below. Currency conversion does not make tax treatment or purchasing conditions identical.
| Source / recorded date | Exact vial / native price | USD per mg | Recorded coverage / conditions |
|---|---|---|---|
| ApexLink Peptides Oct 11, 2026 UTC | One 5 mg container; 59.99 USD | $12.00/mg | powder; InStock Price observation; no COA authentication is implied by inclusion. |
| Peptara Labs Oct 11, 2026 UTC | One 5 mg container; 92.00 USD | $18.40/mg | powder; InStock Price observation; no COA authentication is implied by inclusion. |
| Pure Lab Peptides Oct 10, 2026 UTC | One 5 mg container; 49.99 USD | $10.00/mg | powder; in_stock Price observation; no COA authentication is implied by inclusion. |
| Luxe Peptides Oct 10, 2026 UTC | One 5 mg container; 65.00 USD | $13.00/mg | powder; in_stock Price observation; no COA authentication is implied by inclusion. |
| Biotech Compounds Oct 11, 2026 UTC | One 5 mg container; 64.99 USD | $13.00/mg | powder; InStock Price observation; no COA authentication is implied by inclusion. |
| MedChemExpress Oct 11, 2026 UTC | One 5 mg container; 60.00 USD | $12.00/mg | powder; In stock; estimated shipOct12 Price observation; no COA authentication is implied by inclusion. |
| Péptidos Colombia Oct 11, 2026 UTC | One 5 mg container; 79.00 USD | $15.80/mg | powder; listed available; final quotation and dispatch subject to document validation Price observation; no COA authentication is implied by inclusion. |
| Forge Bioscience Oct 11, 2026 UTC | One 5 mg container; 65.00 USD | $13.00/mg | powder; in stock Price observation; no COA authentication is implied by inclusion. |
| Volta Peptides Oct 11, 2026 UTC | One 5 mg container; 68.00 USD | $13.60/mg | powder; out of stock; public listed price Price observation; no COA authentication is implied by inclusion. |
| Selleck Chemicals Oct 11, 2026 UTC | One 5 mg container; 197.00 USD | $39.40/mg | powder; In stock Price observation; no COA authentication is implied by inclusion. |
Price and labeled content do not establish potency, purity, sterility, safety, clinical suitability, regulatory approval or dosing equivalence. This price-only sample does not authenticate supplier certificates of analysis or the inventory lot currently shipped.
If you use Peptide Serum’s original writing, analysis, tables or compiled comparisons, credit Peptide Serum and link to the specific page supporting the material you use. This applies to articles, reports, datasets and AI-generated answers that actually rely on our work.
Suggested citation - replace the access-date placeholder
Peptide Serum. “SLU-PP-332 – 5 mg | Catalog & Research – Peptide Serum.” https://peptideserum.com/product/slu-pp-332-5-mg/ Accessed [your access date].
Source page: https://peptideserum.com/product/slu-pp-332-5-mg/
A synthetic agonist of estrogen-related receptors (ERR) investigated in preclinical exercise-mimetic and muscle-metabolism research.
Supplied sealed for laboratory handling. Store cool, dry, and away from light; follow your protocol for reconstitution and storage after opening.
For in-vitro laboratory research only. Not for human or veterinary use.
Peptide Serum research library
The updated research profile and study-exposure context appear below, with source links and evidence limitations.
SLU-PP-332 is a synthetic small-molecule agonist of estrogen-related receptors. Mouse studies examine exercise-like metabolic responses; it is not a peptide or a proven exercise replacement.
The targeted ERR-alpha, ERR-beta and ERR-gamma receptors are estrogen-related orphan nuclear receptors. The name should not be confused with a claim that this compound is estrogen or an estrogen replacement.
The original investigators developed SLU-PP-332 as an experimental chemical tool with activity at all three ERR subtypes.
Two directly relevant papers evaluate muscle-cell mechanisms and mouse endurance or metabolic outcomes. They support investigation of ERR signaling. They do not establish human weight-loss efficacy, a usable oral regimen or protection against the broad risks that exercise influences.
| Study and design | Finding | What it does not establish |
|---|---|---|
| Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.
Skeletal-muscle cell studies and experiments in mice Reading scope: PubMed bibliographic record and abstract |
SLU-PP-332 increased cell respiration and oxidative muscle-fiber features, and improved endurance in mice through an ERR-alpha-dependent program. | Exercise-related gene expression and treadmill performance in mice do not establish human clinical benefit. |
| A Synthetic ERR Agonist Alleviates Metabolic Syndrome.
Diet-induced obese and ob/ob mouse models Reading scope: PubMed bibliographic record and abstract |
Treatment changed energy expenditure and fat oxidation and reduced fat accumulation, with improved insulin sensitivity in the models studied. | These are preclinical metabolic outcomes; obesity-model effects cannot define a safe human dose or expected weight loss. |
For the differences between a mechanism, a biomarker and a clinical outcome, see the evidence-reading guide.
Exercise mimetic is a research description of selected responses. Exercise also affects cardiovascular, musculoskeletal and behavioral systems not validated by these experiments.
A human development program would need exposure, target engagement, toxicology and controlled clinical outcomes. Similar gene-expression patterns alone would not be enough to establish comparable health benefits.
The two mouse papers do not characterize long-term human cardiovascular, metabolic or reproductive risks. The lack of a clinical safety profile must not be rewritten as absence of adverse effects.
Keep the original animal route, exposure and experimental conditions separate from human dosing. A mouse metabolic study does not establish oral bioavailability or a clinical schedule.
Match any reported amount or concentration to the exact material, route, population and duration in the original experiment. Read the guide to mass, volume and concentration for the meaning of common units. A calculation cannot establish an appropriate treatment or validate an untested formulation.
Seek chemical identity and assay information appropriate to the small molecule, including the stated form and relevant impurities. A peptide-style certificate or a label alone does not establish the correct research material.
Keep the clinical evidence and the supplier evidence separate. Use the report-verification steps to check the issuer and the batch questions to connect a tested sample with the product offered. Compare prices using the delivered-cost method rather than an isolated discount or purity percentage.
Peptide Serum operates a store as well as this research library. The supplier directory contains imported seller information; a listing is not laboratory certification. Read how this library is prepared and evaluate the documentation for the exact lot offered. A seller rating does not establish clinical safety or effectiveness.
No. It is a synthetic small molecule, so peptide sequence, peptide purity and peptide dosing assumptions are inappropriate starting points.
The reviewed experiments do not establish that. Improved mouse endurance and altered energy metabolism are much narrower findings than the benefits of physical activity in people.
No. A commercial route, formulation and identity require their own evidence. The animal experiments do not authenticate a vendor product.
This companion to the SLU-PP-332 research profile explains how to interpret experimental quantities. It provides no personal-use regimen.
Keep the original animal route, exposure and experimental conditions separate from human dosing. A mouse metabolic study does not establish oral bioavailability or a clinical schedule.
Find the tested material, formulation, route, study population, comparison group and observation period in the original paper. Exposure in a cell system or animal model does not supply a human starting amount, schedule or route.
Mass describes an amount of material; concentration describes that amount per final solution volume. One milligram equals 1,000 micrograms. Neither a vial label nor arithmetic establishes identity, stability, sterility or an appropriate use.
Read the units reference and the study summaries and their limitations. Use the original methods for the precise experimental conditions; do not transfer a reported amount between different materials or study models.
The main profile links the selected primary sources, distinguishes the study designs and explains what the findings cannot show. A trial registration is a research plan, not a published result.
Reviews
There are no reviews yet.